{
  "zip": "541-8564",
  "sector": "",
  "fullTimeEmployees": 3560,
  "longBusinessSummary": "Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER Capsule for improvement of the symptoms in patients with pheochromocytoma; and BRAFTOVI capsules, and MEKTOVI and VELEXBRU tablets for malignant tumors. It also provides GLACTIV and FORXIGA tablets for type 2 diabetes; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; PARSABIV, an intravenous injection for dialysis patients; ONOACT injections for tachyarrhythmia; STAYBLA tablets for overactive bladder; OPALMON tablets to treat peripheral circulatory disorder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; CORALAN for treatment of chronic heart failure; and RECALBON tablets for osteoporosis. In addition, the company is developing products for colorectal, esophageal, gastric or esophago-gastric junction, small and non-small cell lung, ovarian, pancreatic, prostate, biliary tract, hematologic, and head and neck cancers; hepatocellular, urothelial, and virus positive/negative solid carcinoma; glioblastoma; multiple myeloma; malignant pleural mesothelioma; solid tumors; central nervous system, primary testicular, and lymphoplasmacytic; acute myeloid leukemia; melanoma; primary macroglobulinemia; chronic heart failure; Parkinson's disease; structural damage of the joints in rheumatoid arthritis; polymyositis/dermatomyositis; osteoarthritis; enthesopathy; pemphigus; celebral infarction; acromegaly; thrombosis; and autoimmune disease. The company has research and option agreement with Numab Therapeutics AG. Ono Pharmaceutical Co., Ltd. was founded in 1717 and is headquartered in Osaka, Japan.",
  "city": "Osaka",
  "phone": "81 6 6263 5670",
  "country": "Japan",
  "companyOfficers": [],
  "website": "http://www.ono.co.jp",
  "maxAge": 1,
  "address1": "8-2, Kyutaromachi 1-chome",
  "fax": "81 6 6263 2976",
  "industry": "",
  "address2": "Chuo-ku",
  "previousClose": 29,
  "regularMarketOpen": 29,
  "twoHundredDayAverage": 26.490507,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 29,
  "navPrice": null,
  "averageDailyVolume10Day": 12,
  "totalAssets": null,
  "regularMarketPreviousClose": 29,
  "fiftyDayAverage": 29.404545,
  "trailingAnnualDividendRate": null,
  "open": 29,
  "averageVolume10days": 12,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.517875,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 29,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 14821001216,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 46,
  "priceToSalesTrailing12Months": null,
  "dayLow": 29,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 100,
  "fiftyTwoWeekHigh": 31,
  "forwardPE": 16.292135,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 18,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 29,
  "exchange": "PNK",
  "shortName": "ONO PHARMACEUTICAL CO",
  "longName": "Ono Pharmaceutical Co., Ltd.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": true,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "OPHLF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_876950",
  "uuid": "2fc3c55a-9df3-3ac1-8e51-85bbc68455d4",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.22708,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": 1.78,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 514120992,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0.33806,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.17920999,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 464856704,
  "enterpriseValue": 14475142144,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": 0.113,
  "dateShortInterest": null,
  "pegRatio": 13533.3,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 29,
  "logo_url": "https://logo.clearbit.com/ono.co.jp"
}